The AHSN Network has supported many innovators to help advance our health and care system. Find out more about successful innovations supported by the NHS.
Find your nearest AHSN
Maximising Digital Opportunities in Perinatal Mental Health and Wellbeing
Did you know that 20% of women experience mental health problems during the perinatal period? Partners can also experience mental health problems during this time. Utilising digital solutions can support women, partners and families when experiencing perinatal mental health challenges.
Whose Shoes - an innovative approach to coproduction
The ‘Whose Shoes?®’ approach, created by Gill Phillips, is an engaging approach to coproduction, used in over 80 NHS trusts, universities and more.
Placental Growth Factor (PlGF) based testing for pre-eclampsia
Pre-eclampsia (PE) affects approximately 3% of all pregnancies and is a serious cause of maternal and foetal morbidity. There is no definitive test to help diagnose PE and the only 'cure' is delivery of the baby. High suspicion for the disease and a low threshold for admission places a considerable unnecessary burden on the system, something that PlGF based testing aims to alleviate.
Thousands more pregnant women benefit from test to rule out pre-eclampsia following national rollout led by AHSNs
Quick, accurate blood tests which can help rule out pre-eclampsia are improving care for pregnant women and their unborn babies, reducing anxiety and saving the NHS money. AHSNs are leading a rapid adoption project for these tests into maternity units across the country.
Maternity Movement Bracelet
The Maternity Movement Bracelet has been designed to help women monitor patterns in their baby’s movements during their pregnancy and to notice when those patterns change. This was important as changes in a baby’s movement patterns can highlight problems with a baby that may require medical intervention.
Prevention of Cerebral Palsy in PreTerm Labour (PReCePT)
The antenatal administration of magnesium sulphate (MgSO4) to mothers during preterm labour has been demonstrated to reduce the incidence of cerebral palsy. Initially developed by the West of England Academic Health Science Network (AHSN) in collaboration with University Hospitals Bristol NHS Foundation Trust the national PReCePT project sought to increase uptake to 85%.
Thousands more pregnant women benefit from test to rule out pre-eclampsia following national rollout led by the Oxford AHSN
Quick, accurate blood tests which can help rule out pre-eclampsia are improving care for pregnant women and their unborn babies, reducing anxiety and saving the NHS money. AHSNs are leading a rapid adoption project for these tests into maternity units across the country. Rapid uptake means these tests are becoming available to thousands more pregnant women – up from 29,000 in March 2019 to a predicted 200,000+ by the end of December 2019. The award-winning NHS/research/industry partnership has been selected for the NHS England Accelerated Access Collaborative, Innovation Technology Payment and Rapid Uptake programmes in 2019/20 which introduce an accelerated pathway to market for highly transformative innovations.
Birmingham Symptom-specific Obstetric Triage System (BSOTS)
The Birmingham Symptom-specific Obstetric Triage System (BSOTS) was developed to better assess and treat pregnant women who attend hospital with pregnancy related complications or concerns.
Healthy.io is a health-tech company with a mission to improve healthcare outcomes by turning the smartphone into a regulatory approved clinical device. Its first product line, Dip.io, allows patients to do regular urine tests at home using their smartphone cameras and a digital testing kit and measures 10 parameters, indicating a range of infections, chronic illnesses and pregnancy-related complications.